BioCentury
ARTICLE | Company News

MediQuest submits MQX-503 NDA

April 29, 2008 1:09 AM UTC

MediQuest (Bothell, Wash.) submitted an NDA for MQX-503 to treat Raynaud's disease, a circulatory disorder that causes extremities to become cold, painful and discolored. MQX-503 is a topical gel form...